Jupiter Research Capital (Asia) Ltd’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
Jupiter Research Capital (Asia) Ltd's DNTH Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd opened a new position in Dianthus Therapeutics (DNTH) in Q3 2026: 28,330 shares worth $2.49M. The stake represents 0.27% of the portfolio and ranks #84 among its holdings.
246 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd held 28,330 shares of Dianthus Therapeutics worth $2.49M as of Q3 2026.
- Dianthus Therapeutics was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
- Dianthus Therapeutics made up 0.27% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #84 holding.
- 246 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.